HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Timothy W Corson Selected Research

Kinesins

11/2018Observations on spontaneous tumor formation in mice overexpressing mitotic kinesin Kif14.
3/2014KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancer.
1/2014Transcriptional and epigenetic regulation of KIF14 overexpression in ovarian cancer.
6/2007KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer.
2/2007Profiling genomic copy number changes in retinoblastoma beyond loss of RB1.
9/2006KIF14 mRNA expression is a predictor of grade and outcome in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Timothy W Corson Research Topics

Disease

19Neoplasms (Cancer)
01/2021 - 09/2004
15Retinoblastoma (Glioblastoma, Retinal)
03/2020 - 09/2004
9Choroidal Neovascularization
09/2021 - 12/2014
4Eye Diseases (Eye Disease)
09/2021 - 01/2014
4Macular Degeneration (Age-Related Maculopathy)
09/2021 - 01/2018
4Vascular Diseases (Vascular Disease)
01/2021 - 01/2019
3Diabetic Retinopathy (Retinopathy, Diabetic)
09/2021 - 01/2019
3Inflammation (Inflammations)
09/2021 - 01/2014
3Neoplasm Metastasis (Metastasis)
12/2014 - 09/2004
3Breast Neoplasms (Breast Cancer)
03/2014 - 07/2005
2Retinopathy of Prematurity (Retrolental Fibroplasia)
09/2021 - 01/2019
2Retinal Neovascularization
01/2020 - 06/2015
2Toxic Optic Neuropathy
01/2020 - 01/2016
2Pathologic Neovascularization
10/2014 - 01/2014
2Carcinogenesis
03/2014 - 07/2005
1Macular Edema
01/2021
1Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2021
1Mitochondrial Diseases (Mitochondrial Disease)
08/2020
1Uveal melanoma
03/2020
1Glioblastoma (Glioblastoma Multiforme)
01/2020
1Retinal Neoplasms
10/2016
1Oculocerebrorenal Syndrome (Lowe Syndrome)
09/2014
1Triple Negative Breast Neoplasms
03/2014
1Kidney Diseases (Kidney Disease)
07/2011
1Lymphoma (Lymphomas)
02/2011
1Major Depressive Disorder (Major Depressive Disorders)
02/2011
1Bipolar Disorder (Manic Depressive Psychosis)
02/2011
1Genomic Instability
05/2008
1Aneuploidy (Aneuploid)
05/2008
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2007
1Lung Neoplasms (Lung Cancer)
06/2007
1Carcinoma (Carcinomatosis)
06/2007
1Ductal Carcinoma
09/2006
1Ganglion Cysts (Ganglion)
06/2005

Drug/Important Bio-Agent (IBA)

16Retinaldehyde (Retinal)IBA
09/2021 - 09/2004
12Proteins (Proteins, Gene)FDA Link
09/2021 - 09/2004
6KinesinsIBA
11/2018 - 09/2006
5Messenger RNA (mRNA)IBA
01/2014 - 09/2004
4Transcription Factors (Transcription Factor)IBA
09/2021 - 01/2014
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2021 - 01/2014
4Heme (Haem)IBA
01/2021 - 01/2017
4Tumor Viral Antigens (Large T Antigen)IBA
10/2016 - 09/2004
3Ferrochelatase (Heme Synthetase)IBA
01/2021 - 01/2017
3Pharmaceutical PreparationsIBA
01/2017 - 01/2014
2EnzymesIBA
01/2020 - 01/2017
2Griseofulvin (Grifulvin V)FDA LinkGeneric
01/2020 - 01/2017
2Biological ProductsIBA
06/2015 - 07/2011
25,7- dihydroxy- 3- (3- hydroxy- 4- methoxybenzyl)- 6- methoxychroman- 4- oneIBA
06/2015 - 10/2014
2Estrogen ReceptorsIBA
03/2014 - 09/2006
2MicroRNAs (MicroRNA)IBA
01/2014 - 07/2007
2osteoblast cadherinIBA
09/2011 - 09/2004
1Neuroprotective AgentsIBA
09/2021
1CytokinesIBA
01/2021
1Retinal Pigments (Pigments, Visual)IBA
03/2020
1Small Molecule LibrariesIBA
01/2020
1Epoxide HydrolasesIBA
01/2019
1RutheniumIBA
01/2019
1Fatty Acids (Saturated Fatty Acids)IBA
01/2019
1HydrolasesIBA
01/2019
1Small Interfering RNA (siRNA)IBA
01/2017
1Nonsense Codon (Nonsense Mutation)IBA
07/2016
1SH-11037IBA
01/2016
1Aligeron (AS 2)IBA
01/2015
1Chalcone (Benzalacetophenone)IBA
12/2014
1isoliquiritigenin (GU 17)IBA
12/2014
1CurcuminIBA
12/2014
1Inositol Polyphosphate 5-PhosphatasesIBA
09/2014
1ErbB Receptors (EGF Receptor)IBA
03/2014
1Docetaxel (Taxotere)FDA Link
03/2014
1Progesterone Receptors (Progesterone Receptor)IBA
03/2014
1Biomarkers (Surrogate Marker)IBA
03/2014
1enhanced green fluorescent proteinIBA
01/2014
1LuciferasesIBA
01/2014
1LuciferinsIBA
01/2014
1Complement System Proteins (Complement)IBA
01/2014
1Phosphotransferases (Kinase)IBA
05/2012
1Carbonic Anhydrase IIIBA
09/2011
1DNA (Deoxyribonucleic Acid)IBA
09/2011
1triptolideIBA
07/2011
1CalciumIBA
02/2011
1Apoptosis Regulatory ProteinsIBA
02/2011
1N 30IBA
02/2011
1Cyclin-Dependent Kinase Inhibitor p16IBA
05/2008
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
12/2007
1AgarIBA
06/2007
1RNA (Ribonucleic Acid)IBA
06/2007
1chromokinesinIBA
07/2005
1Indicators and Reagents (Reagents)IBA
07/2005

Therapy/Procedure

9Therapeutics
09/2021 - 11/2012
3Lasers (Laser)
01/2021 - 10/2015
2Intravitreal Injections
09/2021 - 01/2020
2Drug Therapy (Chemotherapy)
03/2014 - 02/2007
1Biological Therapy
01/2014
1Long-Term Care
04/2013